A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein alpha required for prolactin gene transcription.

The pituitary-specific homeodomain protein Pit-1 cooperates with other transcription factors, including CCAAT/enhancer binding protein alpha (C/EBPalpha), in the regulation of pituitary lactotrope gene transcription. Here, we correlate cooperative activation of prolactin (PRL) gene transcription by Pit-1 and C/EBPalpha with changes in the subnuclear localization of these factors in living pituitary cells. Transiently expressed C/EBPalpha induced PRL gene transcription in pituitary GHFT1-5 cells, whereas the coexpression of Pit-1 and C/EBPalpha in HeLa cells demonstrated their cooperativity at the PRL promoter. Individually expressed Pit-1 or C/EBPalpha, fused to color variants of fluorescent proteins, occupied different subnuclear compartments in living pituitary cells. When coexpressed, Pit-1 recruited C/EBPalpha from regions of transcriptionally quiescent centromeric heterochromatin to the nuclear regions occupied by Pit-1. The homeodomain region of Pit-1 was necessary for the recruitment of C/EBPalpha. A point mutation in the Pit-1 homeodomain associated with the syndrome of combined pituitary hormone deficiency in humans also failed to recruit C/EBPalpha. This Pit-1 mutant functioned as a dominant inhibitor of PRL gene transcription and, instead of recruiting C/EBPalpha, was itself recruited by C/EBPalpha to centromeric heterochromatin. Together our results suggest that the intranuclear positioning of these factors determines whether they activate or silence PRL promoter activity.

[1]  Cynthia F. Booker,et al.  Imaging the localized protein interactions between Pit-1 and the CCAAT/enhancer binding protein alpha in the living pituitary cell nucleus. , 2003, Molecular endocrinology.

[2]  Gary H Karpen,et al.  Conserved organization of centromeric chromatin in flies and humans. , 2002, Developmental cell.

[3]  Triona Goode,et al.  C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4 , 2001 .

[4]  O. MacDougald,et al.  CCAAT/enhancer binding protein alpha assembles essential cooperating factors in common subnuclear domains. , 2001, Molecular endocrinology.

[5]  Richard N. Day,et al.  Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus. , 2001, Methods.

[6]  Gary H. Karpen,et al.  Determining centromere identity: cyclical stories and forking paths , 2001, Nature Reviews Genetics.

[7]  O. MacDougald,et al.  p300 Coactivates the Adipogenic Transcription Factor CCAAT/Enhancer-binding Protein α* , 2001, The Journal of Biological Chemistry.

[8]  A. Gutierrez-Hartmann,et al.  Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter. , 2001, Nucleic acids research.

[9]  T Misteli,et al.  Protein dynamics: implications for nuclear architecture and gene expression. , 2001, Science.

[10]  Y. Wan,et al.  Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. , 2000, Molecular endocrinology.

[11]  M. Rosenfeld,et al.  Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. , 2000, Science.

[12]  R Y Tsien,et al.  Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Brodsky,et al.  The Pit-1 Homeodomain and β-Domain Interact with Ets-1 and Modulate Synergistic Activation of the Rat Prolactin Promoter* , 2000, The Journal of Biological Chemistry.

[14]  François-Michel Boisvert,et al.  Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA , 2000, The Journal of cell biology.

[15]  S. Asa,et al.  Pit-1 Binding Sites at the Somatotrope-specific DNase I Hypersensitive Sites I, II of the Human Growth Hormone Locus Control Region Are Essential for in Vivo hGH-N Gene Activation* , 1999, The Journal of Biological Chemistry.

[16]  J. Parks,et al.  Heritable disorders of pituitary development. , 1999, The Journal of clinical endocrinology and metabolism.

[17]  Mark Groudine,et al.  A Functional Enhancer Suppresses Silencing of a Transgene and Prevents Its Localization Close to Centromeric Heterochromatin , 1999, Cell.

[18]  K. K. Jacob,et al.  CCAAT/Enhancer-Binding Protein α Is a Physiological Regulator of Prolactin Gene Expression1. , 1999, Endocrinology.

[19]  M. Rosenfeld,et al.  Combinatorial codes in signaling and synergy: lessons from pituitary development. , 1999, Current opinion in genetics & development.

[20]  M. Lane,et al.  Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. , 1999, Genes & development.

[21]  S. Gasser,et al.  Nuclear compartments and gene regulation. , 1999, Current opinion in genetics & development.

[22]  R. Kingston,et al.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. , 1999, Immunity.

[23]  A. Gutierrez-Hartmann,et al.  Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1. , 1999, Molecular endocrinology.

[24]  W. Earnshaw,et al.  Mammalian centromeres: DNA sequence, protein composition, and role in cell cycle progression. , 1999, Experimental cell research.

[25]  A. Fisher,et al.  Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. , 1999, Molecular cell.

[26]  B. Vig,et al.  Decondensation of pericentric heterochromatin alters the sequence of centromere separation in mouse cells , 1998, Chromosoma.

[27]  R. Day,et al.  Selective Inhibition of Prolactin Gene Transcription by the ETS-2 Repressor Factor* , 1998, The Journal of Biological Chemistry.

[28]  O. MacDougald,et al.  The Role of C/EBP Genes in Adipocyte Differentiation* , 1998, The Journal of Biological Chemistry.

[29]  K. Senger,et al.  Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. , 1998, Molecular cell.

[30]  C. Glass,et al.  Signal-specific co-activator domain requirements for Pit-1 activation , 1998, Nature.

[31]  D. Jackson,et al.  The path of transcripts from extra-nucleolar synthetic sites to nuclear pores: transcripts in transit are concentrated in discrete structures containing SR proteins. , 1998, Journal of cell science.

[32]  A. Lamond,et al.  Structure and function in the nucleus. , 1998, Science.

[33]  A. Pombo,et al.  Regional and temporal specialization in the nucleus: a transcriptionally‐active nuclear domain rich in PTF, Oct1 and PIKA antigens associates with specific chromosomes early in the cell cycle , 1998, The EMBO journal.

[34]  I. Weissman,et al.  Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. , 1998, Genes & development.

[35]  J. Lawrence,et al.  Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Roberts,et al.  CDC16 controls initiation at chromosome replication origins. , 1998, Molecular cell.

[37]  Matthias Merkenschlager,et al.  Association of Transcriptionally Silent Genes with Ikaros Complexes at Centromeric Heterochromatin , 1997, Cell.

[38]  T. Maniatis,et al.  The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. , 1997, Molecular cell.

[39]  B. Wasylyk,et al.  Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression , 1997, Molecular and cellular biology.

[40]  M. Rosenfeld,et al.  Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. , 1997, Genes & development.

[41]  B. Brinkley,et al.  Structure and dynamic organization of centromeres/prekinetochores in the nucleus of mammalian cells. , 1996, Journal of cell science.

[42]  R. Getzenberg,et al.  Association of transcription factors with the nuclear matrix , 1996, Journal of cellular biochemistry.

[43]  M. Olive,et al.  Design of a C/EBP-specific, Dominant-negative bZIP Protein with Both Inhibitory and Gain-of-function Properties * , 1996, The Journal of Biological Chemistry.

[44]  T. Maniatis,et al.  Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.

[45]  R. Maurer,et al.  Thyrotropin releasing hormone stimulates transient phosphorylation of the tissue-specific transcription factor, Pit-1. , 1994, The Journal of biological chemistry.

[46]  R. Day,et al.  An alternatively spliced form of Pit-1 represses prolactin gene expression. , 1994, Molecular endocrinology.

[47]  M. Karin,et al.  GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. , 1993, Genes & development.

[48]  F. Wondisford,et al.  A Mutation in the POU-Homeodomain of Pit-1 Responsible for Combined Pituitary Hormone Deficiency , 1992, Science.

[49]  A. Gutierrez-Hartmann,et al.  Interaction of basal positive and negative transcription elements controls repression of the proximal rat prolactin promoter in nonpituitary cells , 1992, Molecular and cellular biology.

[50]  S. Camper,et al.  The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. , 1990, Genomics.

[51]  Larry W. Swanson,et al.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 , 1990, Nature.

[52]  R. Day,et al.  Clustered point mutation analysis of the rat prolactin promoter. , 1990, Molecular endocrinology.

[53]  M. Rosenfeld,et al.  The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1—Pit-1 interactions , 1990, Cell.

[54]  L W Swanson,et al.  Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. , 1990, Genes & development.

[55]  M. Karin,et al.  Dissection of functional domains of the pituitary-specific transcription factor GHF-1 , 1989, Nature.

[56]  R. Jaenisch,et al.  Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? , 1989, Genes & development.

[57]  S. McKnight,et al.  Isolation of a recombinant copy of the gene encoding C/EBP. , 1988, Genes & development.

[58]  B. Hamkalo,et al.  Mouse satellite DNA, centromere structure, and sister chromatid pairing , 1986, The Journal of cell biology.

[59]  W. Schnedl,et al.  5-Methylcytosine localised in mammalian constitutive heterochromatin , 1974, Nature.

[60]  R. Day,et al.  BMC Cell Biology BioMed Central Research article BMC 32002, Cell Biology , 2001 .

[61]  F. Schaufele,et al.  CCAAT/Enhancer-binding Protein (cid:1) Alters Histone H3 Acetylation at Large Subnuclear Domains* , 2001 .

[62]  松田 永照.  Targeting of Kruppel-associated Box-containing Zinc-finger Proteins to Centromeric Heterochromatin : Implication for the Gene Silencing Mechanisms , 2001 .

[63]  K. K. Jacob,et al.  CCAAT/enhancer-binding protein alpha is a physiological regulator of prolactin gene expression. , 1999, Endocrinology.

[64]  M. Merika,et al.  Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. , 1998, Molecular cell.

[65]  F. Schaufele.  CCAAT/Enhancer-binding Protein (cid:97) Activation of the Rat Growth Hormone Promoter in Pituitary Progenitor GHFT1-5 Cells* , 1996 .